Nano Dimension News - June 2026
Oramed Boosts Nano Dimension Stake, Opposing $890M Healthcare AI Merger
Oramed Pharmaceuticals increased its stake in Nano Dimension to 7.2% on June 18, 2026. The shareholder formally opposed the proposed business combination with...
🟢 Nano Dimension Ltd is trading 5.2% up today in rebound after health AI pivot selloff
Nano Dimension Ltd is trading 5.2% up at $1.31, staging a recovery following a sharp decline triggered by its unexpected strategic shift into health AI. • The...
Nano Dimension Signs Term Sheet for Merger with AI Health Company Infinite Epigenetics
Nano Dimension has entered into a non-binding term sheet for a proposed business combination with Infinite Epigenetics, Inc., an AI-powered preventive health...